Prognosis

It’s Getting Harder to Know If U.S. Vaccine Makers Are Meeting Their Targets

More and more doses are being shipped through a federal program that’s less transparent

Syringes of Pfizer-BioNTech Covid-19 vaccine

Photographer: Scotty Perry/Bloomberg
Lock
This article is for subscribers only.

Knowing which vaccines are being supplied in the U.S. is just as important as knowing how many shots are going into arms.

But because of a bifurcated U.S. distribution system, the public is getting less and less detailed information from the federal government on how many doses each vaccine manufacturer is actually delivering. It’s a situation that makes it harder to know if drugmakers are meeting their delivery commitments and also how the federal government is allocating shots.